DeKalb buy clears hurdle
Monsanto Co. said it received regulatory clearance for its long delayed acquisition of DeKalb Genetics Corp, a $2.3billion deal that increases the St. Louis company's crop-bio-technology power. To
Monsanto Co. said it received regulatory clearance for its long delayed acquisition of DeKalb Genetics Corp, a $2.3billion deal that increases the St. Louis company's crop-bio-technology power. To